Berlin-Brandenburg Pregnancy Cohort
Recruiting now
Conditions studied: Preeclampsia, Pregnancy Complications, Diabetes Mellitus in Pregnancy
In brief
This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.
Key facts
- Study ID
- NCT03313024
- Run by
- Charite University, Berlin, Germany
- People needed
- 1580
- Starts
- 2017-09-26
- Expected to finish
- 2027-10-01
- Last updated by the study team
- 2018-08-14
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- healthy pregnant women after giving informed consent
- pregnant with diagnosis of preeclampsia, gestational hypertension or gestational diabetes
You may not qualify if…
- infections
- alcohol and drug abuse
- manifest and chronic diseases
Where it is running
- Experimental and Clinical Research Center (ECRC) — Berlin, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.